Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency after One Year

Journal of Diabetes Science and Technology

Volumn 10, Issue 2, 2016, Pages 383-388

  Chamberlain, James J ^a   Dopita, Dana ^a   Gilgen, Emily ^a   Neuman, Annie ^a  

^a St Mark's Hospital Salt Lake City   (United States)

Author keywords

CGM; continuous glucose monitoring; emergency; hypoglycemia; SMBG

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; DISEASE ASSOCIATION; EMERGENCY TREATMENT; FEMALE; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; SELF MONITORING; ANALYSIS; BLOOD; FEAR; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MIDDLE AGED; PSYCHOLOGY; UTILIZATION; YOUNG ADULT;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEAR; FEMALE; HUMANS; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85009268766     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296815604633     Document Type: Article

References (18)

1. Pickup JC, Freeman SC, Sutton AJ,. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011; 343: d3805.
2. Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012; 55 (12): 3155-3162.
3. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J,. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011; 34 (4): 795-800.
4. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care. 2010; 33 (1): 17-22.
5. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006; 29 (12): 2730-2732.
6. Raccah D, Sulmont V, Reznik Y, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009; 32 (12): 2245-2250.
7. O'Connell MA, Donath S, O'Neal DN, et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia. 2009; 52 (7): 1250-1257.
8. Bailey TS, Zisser HC, Garg SK,. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther. 2007; 9 (3): 203-210.
9. Frontino G, Bonfanti R, Scaramuzza A, et al. Sensor-augmented pump therapy in very young children with type 1 diabetes: an efficacy and feasibility observational study. Diabetes Technol Ther. 2012; 14 (9): 762-764.
10. Polonsky WH, Hessler D,. Perceived accuracy in continuous glucose monitoring: understanding the impact on patients. J Diabetes Sci Technol. 2015; 9 (2): 339-341.
11. Polonsky WH, Hessler D,. What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users. Diabetes Technol Ther. 2013; 15 (4): 295-301.
12. Matuleviciene V, Joseph JI, Andelin M, et al. A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther. 2014; 16 (11): 759-767.
13. Chamberlain J, Dopita D, Gilgen E,. Persistence of continuous glucose monitoring use in a community setting 1 year after purchase. Clin Diabetes. 2013; 31: 106-109.
14. Pettus J, Price D, Edelman S,. How patients with type 1 diabetes translate continuous glucose monitoring data into diabetes management decisions. Endocr Pract. 2015; 21: 613-620.
15. Cryer PE,. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract. 2008; 14 (6): 750-756.
16. Fanelli CG, Porcellati F, Pampanelli S, Bolli GB,. Insulin therapy and hypoglycaemia: the size of the problem. Diabetes Metab Res Rev. 2004; 20 (suppl 2): S32-S42.
17. Smith CB, Choudhary P, Pernet A, Hopkins D, Amiel SA,. Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit. Diabetes Care. 2009; 32 (7): 1196-1198.
18. Choudhary P, Ramasamy S, Green L, et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care. 2013; 36 (12): 4160-4162.